Largest biotech by total assets

Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.

Amgen leads the 24 biotech ranked by total assets, at $90.6B, ahead of Gilead Sciences ($59B) and Biogen ($29.4B). Figures as of 17 Nov 2026, 17:20 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Amgen$90.6B
Median
$2.6B
Combined market value
$850.2B
Countries
5

Market values as of .

Largest biotech by total assets
#CompanyTotal assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health Care$90.6B$248.5B$459.50 0.61% down 34% up United States
2Gilead SciencesGILD · Health Care$59B$210.9B$170.07 1.48% up 32% up United States
3BiogenBIIB · Health Care$29.4B$37.1B$251.16 0.19% down 49% up United States
4BioNTechBNTX · Health Care$24.4B$21.1B$85.19 0.08% down 17% down Germany
5ModernaMRNA · Health Care$12.3B$84B$207.60 3.57% down 764% up United States
6argenxARGX · Health Care$8.7B$59.6B$947.13 0.40% down 4% up Belgium
7QiagenQGEN · Health Care$6.3B$10.3B$49.83 0.04% up 12% up Netherlands
8Neurocrine BiosciencesNBIX · Health Care$4.6B$16.8B$165.65 0.21% up 19% up United States
9VaxcytePCVX · Health Care$3B$9.5B$60.30 2.13% down 24% up United States
10RepligenRGEN · Health Care$2.9B$10.4B$162.46 0.20% down 6% up United States
11ExelixisEXEL · Health Care$2.8B$16.6B$68.18 1.61% up 57% up United States
12Bio-TechneTECH · Health Care$2.6B$11.4B$72.78 0.01% down 25% up United States
13Halozyme TherapeuticsHALO · Health Care$2.5B$10.9B$95.69 0.84% down 38% up United States
14Revolution MedicinesRVMD · Health Care$2.4B$35.6B$164.57 1.38% down 136% up United States
15CRISPR TherapeuticsCRSP · Health Care$2.3B$3.9B$40.55 0.45% up 24% down Switzerland
16Kymera TherapeuticsKYMR · Health Care$1.7B$10.4B$122.26 2.85% down 96% up United States
17Krystal BiotechKRYS · Health Care$1.3B$8.8B$297.75 0.05% down 46% up United States
18ImmunovantIMVT · Health Care$957M$6.9B$33.25 0.09% down 40% up United States
19CG OncologyCGON · Health Care$791.6M$7.1B$79.94 5.71% down 99% up United States
20Twist BioscienceTWST · Health Care$641.9M$7.1B$107.74 2.57% up 304% up United States
21Adaptive BiotechnologiesADPT · Health Care$512.7M$4.6B$28.50 2.26% up 103% up United States
22ImmunityBioIBRX · Health Care$501.9M$6.5B$6.13 2.42% up 185% up United States
23Scholar Rock HoldingSRRK · Health Care$404.3M$5.5B$45.11 1.27% up 12% up United States
24Kodiak SciencesKOD · Health Care$351.5M$6.3B$96.97 3.73% down 424% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period.

Questions and answers

Which biotech rank first by total assets?

Amgen ($90.6B), Gilead Sciences ($59B) and Biogen ($29.4B) are the top three of the 24 biotech ranked by total assets as of 17 Nov 2026, 17:20 UTC.

How many biotech are in this ranking?

24 are ranked by total assets.

What are these biotech worth together?

Their combined market value is $850.2B as of 17 Nov 2026, 17:20 UTC.

What does ranking by total assets measure?

Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest biotech by total assets”, data as of 17 November 2026. https://funkfolio.com/companies/category/biotech?by=total-assets

Underlying data: Yahoo Finance; SEC EDGAR.